Kangqi Ren

Long-Term Survival After Salvage Thoracic Surgery on a Patient with ALK-Rearranged Metastatic Lung Adenocarcinoma After Progression on Targeted Therapy

Guang-gui Ding, Lin Yang, Shu-Qing Xie, 2021, OncoTargets and therapy.

Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinoma.

T. Yu, Quanzhou Peng, Guang-gui Ding, 2021, Immunotherapy.

miR-10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway

Zhenlian Wang, Bin Peng, Guang-gui Ding, 2020, Oncology reports.

Prognostic and immunotherapeutic implications of bilirubin metabolism‐associated genes in lung adenocarcinoma

Xiean Ling, Kangqi Ren, Tonghai Huang, 2024, Journal of cellular and molecular medicine.

Transcription factor Yin Yang 1 enhances epithelial-mesenchymal transition, migration, and stemness of non-small cell lung cancer cells by targeting sonic hedgehog.

Xiean Ling, Kangqi Ren, Tonghai Huang, 2024, Molecular and cellular biochemistry.